Skip to main content
SpringerLink
Log in

Adjuvant disease induced by mycobacteria, determinants of arthritogenicity

  • Symposium 2 Chronic Inflammation: Cellular Events
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Genetic, endocrine and immunological factors are probably involved in adjuvant polyarthritis. The nature of the vehicle and of the mycobacterial components administered also has a major influence. It was originally assumed that arthritogenicity and adjuvanticity of mycobacterial fractions such as wax D were intimately related. Our previous findings showed that the water soluble adjuvant (WSA) ofM. smegmatis which could substitute for mycobacterial cells in Freund's complete adjuvant and induce delayed hypersensitivity was not arthritogenic in the Wistar rat. We have since observed that auto-immune diseases could be elicited by WSA. Therefore experiments were repeated using the very susceptible Lewis strain. The activity of cord factor and of various mycobacterial preparations suspended in mineral or in peanut oil was also evaluated in mice and in normal or hypophysectomized rats.

Our present findings confirm the absence of arthritogenicity of WSA in the Lewis strain. They also indicate that cord factor with WSA does not suffice to induce a generalized adjuvant disease, but that a mycobacterial component which could be susceptible to lysozyme treatment is required also. However, the local inflammation of the injected limb was produced by a preparation of cord factor administered in mineral or even in peanut oil. This was observed in normal or hypophysectomized rats and in Swiss mice which were not susceptible to the generalized disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A.F. Coburn, C.E. Graham and J. Haninger,Effect of egg yolk diets on anaphylactic arthritis (passive Arthus phenomenon) in guinea-pigs, J. exp. Med.100, 425–435 (1954).

    Article  PubMed  Google Scholar 

  2. P. Stastny and M. Ziff,Homologous disease in the adult rat: a model for auto-immune disease, Ann. N.Y. Acad. Sci.99, 663–669 (1962).

    PubMed  Google Scholar 

  3. C.M. Pearson,Development of arthritis, periarthritis and periostitis in rats given adjuvants, Proc. Soc. exp. Biol. Med.91, 95–101 (1956).

    PubMed  Google Scholar 

  4. C.M. Pearson and F.D. Wood,Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvants. VII. Pathologic details of the arthritis and spondylitis, Am. J. Pathol.42, 73–95 (1963).

    PubMed  Google Scholar 

  5. L. Sokoloff and G.E. Jay,Natural history of degenerative joint disease in small laboratory animals. IV. Degenerative joint disease in the laboratory rat, AMA Arch. Pathol.62, 140–143 (1956).

    PubMed  Google Scholar 

  6. M.A. Alspaugh and G.L. Van Hoosier, Jr.,Naturally occurring and experimentally-induced arthritidis in rodents. A review of the literature, Lab. Animal. Sci.23, 724–742 (1973).

    Google Scholar 

  7. A. Volkman and F.M. Collins,Pathogenesis of Salmonella-associated arthritis in the rat, Inf. Immun.11, 222–230 (1975).

    Google Scholar 

  8. L. Sokoloff, L.B. Crittenden and R.S. Yamamoto et al.,The genetics of degenerative joint disease in mice, Arthritis Rheum.5, 531–546 (1962).

    PubMed  Google Scholar 

  9. F. Perlik and Z. Zidek,Breeding experiments on the frequency of adjuvant arthritis in the rat, Ann. Rheum. Dis.32, 72–74 (1973).

    PubMed  Google Scholar 

  10. Z. Zidek and F. Perlik,Genetic control of adjuvant-induced arthritis in rats, J. Pharm. Pharmac.23, 389–390 (1971).

    Google Scholar 

  11. J.T. Sharp, B.H. Waksman, C.M. Pearson and S. Madoff,Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. IV. Examination of tissues and fluids for infectious agents, Arthritis Rheum.4, 169–175 (1961).

    Google Scholar 

  12. C.M. Pearson and F.D. Wood,Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. I. General clinical and pathological characteristics and some modifying factors, Arthritis Rheum.2, 440–459 (1959).

    Google Scholar 

  13. C.M. Pearson, F.D. Wood, E.G. McDaniel and F. Daft,Adjuvant arthritis induced in germ-free rats, Proc. Soc. exp. Med.112, 91–93 (1963).

    Google Scholar 

  14. C.M. Pearson and F.D. Wood,Passive transfer of adjuvant arthritis by lymph node or spleen cells, J. exp. Med.120, 547–560 (1964).

    Google Scholar 

  15. I. Gery and B.H. Waksman,Studies of the mechanism whereby adjuvant disease is suppressed in rats pretreated with mycobacteria, Int. Arch. Allergy31, 57–68 (1967).

    PubMed  Google Scholar 

  16. M.H. Flax and B.H. Waksman,Further and immunologic studies of adjuvant disease in the rat, Int. Arch. Allergy23, 331–347 (1963).

    PubMed  Google Scholar 

  17. J.L. Kalliomaki, H.A. Saarimaa and P. Toivanen,Inhibition by 6-mercaptopurine of polyarthritis induced by Freund's adjuvant, Ann. Rheum. Dis.23, 78–80 (1964).

    PubMed  Google Scholar 

  18. H.L. Currey and M. Ziff,Suppression of experimentally induced polyarthritis in the rat by heterologous antilymphocyte serum, Lancet2, 889–891 (1966).

    Article  PubMed  Google Scholar 

  19. I. Gery and B.H. Waksman,Competition of antigens in adjuvant disease of rats, Arthritis Rheum.10, 240–244 (1967).

    PubMed  Google Scholar 

  20. B.H. Waksman, C.M. Pearson and J.T. Sharp,Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen, J. Immun.85, 403–417 (1960).

    PubMed  Google Scholar 

  21. D.T. Walz, M.J. Di Martino, J.H. Kuch and W. Zuccarello,Adjuvant-induced arthritis in rats. I. Temporal relationship of physiological, biochemical and hematological parameters, Proc. Soc. exp. Biol. Med.137, 907–910 (1971).

    PubMed  Google Scholar 

  22. F.W.J. Beck and M.W. Whitehouse,I. Drug sensitivity of rat adjuvant arthritis induced with ‘adjuvants’ containing no mineral oil components, Proc. Soc. exp. Biol. Med.146, 665–669 (1974).

    PubMed  Google Scholar 

  23. R.J. Perper, B. Alvarez, C. Colombo and H. Schroder,The use of a standardized adjuvant arthritis assay to differentiate between anti-inflammatory and immunosuppressive agents, Proc. Soc. exp. Biol. Med.137, 506–512 (1971).

    Google Scholar 

  24. B.B. Newbould,Chemotherapy of arthritis induced in rats by mycobacterial adjuvant, Br. J. Pharmac.21, 127–136 (1963).

    Google Scholar 

  25. A. Adam, R. Ciorbaru, J.F. Petit, E. Lederer, L. Chedid, A. Lamensans, F. Parant, M. Parant, J.P. Rosselet and F.M. Berger,Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca, Infect. Immunity7, 855–861 (1973).

    Google Scholar 

  26. A. Adam, R. Ciorbaru, J.F. Petit and E. Lederer,Isolation and properties of a macromolecular, water soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis, Proc. nat. Acad. Sci. USA69, 851–854 (1972).

    PubMed  Google Scholar 

  27. A.A. Hirata and M.W. Brandiss,Passive hemagglutination procedures for protein and polysaccharide antigens using erythrocytes stabilized by anhydrides, J. Immun.100, 641–648 (1968).

    PubMed  Google Scholar 

  28. A. Adam, F. Ellouz, R. Ciorbaru, J.F. Petit and E. Lederer,Peptidoglycan adjuvants. Minimal structure required for activity. Z. Immun. exp. und Klin. Immun.149, 341–349 (1975).

    Google Scholar 

  29. L. Chedid, M. Parant, F. Parant, R.H. Gustafson and F.M. Berger,Biological study of a non-toxic, water soluble immuno-adjuvant from mycobacterial cell walls, Proc. nat. Acad. Sci. USA69, 855–858 (1972).

    PubMed  Google Scholar 

  30. F. Audibert, M. Parant, J.F. Petit and A. Adam,Activité arthrogène de différentes préparations mycobactériennes, C. r. Acad. Sci., Paris277, 2097–2100 (1973).

    Google Scholar 

  31. C.M. Pearson and F.D. Wood,Factors which modify adjuvant induced arthritis in rats, Arthritis Rheum.5, 654–663 (1962).

    Google Scholar 

  32. C.M. Pearson, B.H. Waksman and J.T. Sharp,Studies of arthritis and other lesions induced in rats by mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes. Comparison of the experimental process with human disease, J. exp. Med.113, 485–510 (1961).

    Article  PubMed  Google Scholar 

  33. F.D. Wood, C.M. Pearson and A. Tanaka,Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats, Int. Arch. Allergy35, 456–467 (1969).

    PubMed  Google Scholar 

  34. M. Modolell, G.A. Luckenbach, M. Parant and P.G. Munder,The adjuvant activity of a mycobacterial water soluble adjuvant (WSA) in vitro. I. The requirement for macrophages, J. Immun.113, 395–403 (1974).

    PubMed  Google Scholar 

  35. D. Juy and L. Chedid,Comparison between macrophage activation and enhancement of non specific resistance to tumors by mycobacterial immuno-adjuvant, Proc. nat. Acad. Sci. USA72, in press (1975).

  36. C. Bona, C. Heuclin and L. Chedid,Enhancement of human mixed-lymphocyte cultures by a water soluble adjuvant. Recent Results in Cancer Research, vol. 47 (Eds. G. Mathé, R. Weiner; Springer Verlag, Berlin, Heidelberg, New York 1974), p. 197–200.

    Google Scholar 

  37. B. Sharma, O. Kohashi, M.R. Mickey and P.I. Terasaki,Effect of water soluble adjuvants on in vitro lymphocyte immunization, Cancer Res.35, 666–669 (1975).

    PubMed  Google Scholar 

  38. F. Toullet, F. Audibert, L. Chedid and G.A. Voisin,Production d'une orchiepididymite aspermatogénétique auto-immune (OAAI) chez le cobaye à l'aide d'un adjuvant hydrosoluble extrait de Mycobacterium smegmatis, Ann. Immun.125C, 901–910 (1974).

    Google Scholar 

  39. R. Lebar and G.A. Voisin,Production d'une encéphalomyélite allergique expérimentale auto-immune (EAE) chez le cobaye à l'aide d'un adjuvant hydrosoluble extrait de Mycobacterium smegmatis, Ann. Immun.125C, 911–916, (1974).

    Google Scholar 

  40. T.J. Meyer, I. Azuma and E.E. Ribi,Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs, Immunology28, 219–229 (1975).

    PubMed  Google Scholar 

  41. F. Bonhomme, C. Boucheron, D. Migliore and P. Jolles,Nouvelles recherches concernant l'effet inhibiteur exercé par des fractions acétylées de cires D provenant de Mycobacterium tuberculosis var.hominis, sur les propriétés arthrogènes des cires D (fraction peptidoglycolipidique) non modifiées, C. r. Acad. Sci., Paris265, 2115–2117 (1967).

    Google Scholar 

  42. F. Paronetto,Studies on experimental arthritis induced by Corynebacterium rubrum. I. Localization of the arthritogenic factor in the cell walls, Arthritis Rheum.15, 36–40 (1972).

    PubMed  Google Scholar 

  43. A. Bekierkunst, I.S. Levij, E. Yarkoni, E. Vilkas, A. Adam and E. Lederer,Granulomas formation induced in mice by chemically defined mycobacterial fraction, J. Bact.100, 95–102 (1969).

    PubMed  Google Scholar 

  44. T. Borsos and H.J. Rapp,Antigenic relationship between Mycobacterium bovis (BCG) and a guinea-pig hepatoma, J. nat. Cancer Inst.51, 1085 (1973).

    PubMed  Google Scholar 

  45. G. Jasmin and P. Bois,Polyarthritis produced in rats by treatment with prolactin and growth hormone, Endocrinology65, 494–499 (1959).

    PubMed  Google Scholar 

  46. P. Bois and H. Selye,Interactions between STH and corticoids in the regulation of somatic growth, inflammation and lymphatic tissue development, Growth19, 107 (1955).

    PubMed  Google Scholar 

  47. S.J. Piliero and C. Colombo,Action of anti-inflammatory drugs on the lysozyme activity and turbidity of serum from rats with adjuvant arthritis or endocrine deficiency, J. Pharmac. exp. Ther.165, 294–299 (1969).

    Google Scholar 

  48. M.W. Whitehouse, K.J. Orr, W.J. Beck and C.M. Pearson,Freund's adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition, Immunology27, 311–330 (1973).

    Google Scholar 

  49. F. Audibert and L. Chedid,Augmentation de la réponse immunitaire par administration d'émulsions à base d'huile végétale métabolisable, C. r. Acad. Sci., Paris280, 1629–1632 (1975).

    Google Scholar 

Download references

Author information

Author notes

  1. Françoise Audibert & Louis Chedid

    Present address: Immunothérapie Expérimentale, Institut Pasteur, 28, rue du Dr-Roux, F-75015, Paris, France

Authors and Affiliations

  1. Institut National de la Santé et de la Recherche Médicale et Institut Pasteur, Paris, France

    Françoise Audibert & Louis Chedid

Authors
  1. Françoise Audibert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Louis Chedid
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Audibert, F., Chedid, L. Adjuvant disease induced by mycobacteria, determinants of arthritogenicity. Agents and Actions 6, 75–85 (1976). https://doi.org/10.1007/BF01972188

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01972188

Keywords

Search

Navigation